These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 11034937)

  • 1. Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled study.
    English KM; Steeds RP; Jones TH; Diver MJ; Channer KS
    Circulation; 2000 Oct; 102(16):1906-11. PubMed ID: 11034937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina. A randomized, double-blind, placebo-controlled study].
    Romanò M
    Ital Heart J Suppl; 2001 Feb; 2(2):203-4. PubMed ID: 11255887
    [No Abstract]   [Full Text] [Related]  

  • 3. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
    Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R
    Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.
    Thadani U; Ezekowitz M; Fenney L; Chiang YK
    Circulation; 1994 Aug; 90(2):726-34. PubMed ID: 8044941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent transdermal nitroglycerin therapy. Decreased anginal threshold during the nitrate-free interval.
    Parker JD; Parker AB; Farrell B; Parker JO
    Circulation; 1995 Feb; 91(4):973-8. PubMed ID: 7850984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot double-blind randomized placebo-controlled study of molsidomine 16 mg once-a-day in patients suffering from stable angina pectoris: correlation between efficacy and over time plasma concentrations.
    Messin R; Fenyvesi T; Carreer-Bruhwyler F; Crommen J; Chiap P; Hubert P; Dubois C; Famaey JP; Géczy J
    Eur J Clin Pharmacol; 2003 Jul; 59(3):227-32. PubMed ID: 12734607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipyridamole in chronic stable angina pectoris; a randomized, double blind, placebo-controlled, parallel group study.
    Picano E;
    Eur Heart J; 2001 Oct; 22(19):1785-93. PubMed ID: 11549300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life.
    Malkin CJ; Pugh PJ; Morris PD; Kerry KE; Jones RD; Jones TH; Channer KS
    Heart; 2004 Aug; 90(8):871-6. PubMed ID: 15253956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and chronic antianginal efficacy of continuous twenty-four-hour application of transdermal nitroglycerin. Steering Committee, Transdermal Nitroglycerin Cooperative Study.
    Am J Cardiol; 1991 Nov; 68(13):1263-73. PubMed ID: 1951111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dipyridamole at the usual oral dose on exercise-induced myocardial ischemia in stable angina pectoris.
    Tsuya T; Okada M; Horie H; Ishikawa K
    Am J Cardiol; 1990 Aug; 66(3):275-8. PubMed ID: 2195863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of a metabolic modulator drug in chronic stable angina: review of evidence from clinical trials.
    Chaitman BR
    J Cardiovasc Pharmacol Ther; 2004 Sep; 9 Suppl 1():S47-64. PubMed ID: 15378131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term efficacy of continuous and intermittent use of transdermal nitroglycerin in stable angina pectoris.
    de Milliano PA; Koster RW; Bär FW; Janssen J; de Cock C; Schelling A; van de Bos A
    Am J Cardiol; 1991 Oct; 68(9):857-62. PubMed ID: 1927943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina.
    DeMots H; Glasser SP
    J Am Coll Cardiol; 1989 Mar; 13(4):786-95. PubMed ID: 2494240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized placebo controlled, double-blind, crossover trial of transdermal nitroglycerin in stable angina pectoris.
    Rezaković DE; Pavicić L; Majacić M
    Eur Heart J; 1988 Jan; 9 Suppl A():73-81. PubMed ID: 3137073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Terminalia arjuna in chronic stable angina: a double-blind, placebo-controlled, crossover study comparing Terminalia arjuna with isosorbide mononitrate.
    Bharani A; Ganguli A; Mathur LK; Jamra Y; Raman PG
    Indian Heart J; 2002; 54(2):170-5. PubMed ID: 12086380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study of the transdermal application of testosterone gel to the penile skin for the treatment of hypogonadotropic men with erectile dysfunction.
    Schultheiss D; Hiltl DM; Meschi MR; Machtens SA; Truss MC; Stief CG; Jonas U
    World J Urol; 2000 Dec; 18(6):431-5. PubMed ID: 11204264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of anti-ischemic and antianginal effect at trough plasma concentration and safety of trimetazidine MR 35 mg in patients with stable angina pectoris: a multicenter, double-blind, placebo-controlled study.
    Sellier P; Broustet JP
    Am J Cardiovasc Drugs; 2003; 3(5):361-9. PubMed ID: 14728070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discontinuous transdermal nitroglycerin as treatment for stable angina in the elderly: a double-blind multicentre study. The Transdermal TNG Trial Group of Istituto Nazionale Ricovero e Cura Anziani (I.N.R.C.A.).
    Paciaroni E; Luca C
    Eur Heart J; 1991 Oct; 12(10):1076-80. PubMed ID: 1782932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial.
    Borer JS; Fox K; Jaillon P; Lerebours G;
    Circulation; 2003 Feb; 107(6):817-23. PubMed ID: 12591750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.